96-15992. Atlantis Corp., Withdrawal of Food Additive Petition  

  • [Federal Register Volume 61, Number 122 (Monday, June 24, 1996)]
    [Notices]
    [Page 32443]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-15992]
    
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Food and Drug Administration
    [Docket No. 94F-0047]
    
    
    Atlantis Corp., Withdrawal of Food Additive Petition
    
    AGENCY: Food and Drug Administration, HHS.
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing the 
    withdrawal, without prejudice to a future filing, of a food additive 
    petition (FAP 4A4409) proposing that the food additive regulations be 
    amended to provide for the safe use of shark liver oil as a dietary 
    supplement for humans.
    FOR FURTHER INFORMATION CONTACT: Lawrence J. Lin, Center for Food 
    Safety and Applied Nutrition (HFS-206), Food and Drug Administration, 
    200 C St. SW., Washington, DC 20204, 202-418-3103.
    SUPPLEMENTARY INFORMATION: In a notice published in the Federal 
    Register of March 24, 1994 (59 FR 13970), FDA announced that a food 
    additive petition (FAP 4A4409) had been filed by Atlantis Corp., 15 
    Tommy's Lane, East Freetown, MA 02717. The petition proposed to amend 
    the food additive regulations to provide for the safe use of shark 
    liver oil as a dietary supplement for humans. Atlantis Corp. has now 
    withdrawn the petition without prejudice to a future filing (21 CFR 
    171.7).
    
        Dated: June 10, 1996.
    Alan M. Rulis,
    Director, Office of Premarket Approval, Center for Food Safety and 
    Applied Nutrition.
    [FR Doc. 96-15992 Filed 6-21-96; 8:45 am]
    BILLING CODE 4160-01-F-----
    
    

Document Information

Published:
06/24/1996
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
96-15992
Pages:
32443-32443 (1 pages)
Docket Numbers:
Docket No. 94F-0047
PDF File:
96-15992.pdf